nodes	percent_of_prediction	percent_of_DWPC	metapath
Rizatriptan—CYP1A2—Anastrozole—breast cancer	0.108	0.401	CbGbCtD
Rizatriptan—CYP1A2—Toremifene—breast cancer	0.0986	0.367	CbGbCtD
Rizatriptan—CYP1A2—Tamoxifen—breast cancer	0.036	0.134	CbGbCtD
Rizatriptan—CYP1A2—Fluorouracil—breast cancer	0.0265	0.0987	CbGbCtD
Rizatriptan—Melatonin—MT3—breast cancer	0.00324	0.246	CrCbGaD
Rizatriptan—Melatonin—NQO2—breast cancer	0.00276	0.209	CrCbGaD
Rizatriptan—Sumatriptan—SLCO1B1—breast cancer	0.00211	0.16	CrCbGaD
Rizatriptan—Melatonin—CYP1B1—breast cancer	0.000933	0.0708	CrCbGaD
Rizatriptan—Sumatriptan—ABCG2—breast cancer	0.000917	0.0695	CrCbGaD
Rizatriptan—Melatonin—CYP19A1—breast cancer	0.000685	0.0519	CrCbGaD
Rizatriptan—Melatonin—ESR1—breast cancer	0.00063	0.0478	CrCbGaD
Rizatriptan—Almotriptan—CYP2D6—breast cancer	0.000555	0.0421	CrCbGaD
Rizatriptan—Melatonin—CYP1A1—breast cancer	0.000504	0.0382	CrCbGaD
Rizatriptan—Almotriptan—CYP3A4—breast cancer	0.000476	0.0361	CrCbGaD
Rizatriptan—Sumatriptan—ABCB1—breast cancer	0.000381	0.0289	CrCbGaD
Rizatriptan—Anorexia—Capecitabine—breast cancer	0.000122	0.000232	CcSEcCtD
Rizatriptan—Angiopathy—Methotrexate—breast cancer	0.000121	0.000232	CcSEcCtD
Rizatriptan—Vomiting—Mitoxantrone—breast cancer	0.000121	0.000231	CcSEcCtD
Rizatriptan—Vomiting—Irinotecan—breast cancer	0.000121	0.000231	CcSEcCtD
Rizatriptan—Dizziness—Fluorouracil—breast cancer	0.000121	0.000231	CcSEcCtD
Rizatriptan—Rash—Irinotecan—breast cancer	0.00012	0.000229	CcSEcCtD
Rizatriptan—Rash—Mitoxantrone—breast cancer	0.00012	0.000229	CcSEcCtD
Rizatriptan—Dermatitis—Mitoxantrone—breast cancer	0.00012	0.000229	CcSEcCtD
Rizatriptan—Dermatitis—Irinotecan—breast cancer	0.00012	0.000229	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Docetaxel—breast cancer	0.00012	0.000229	CcSEcCtD
Rizatriptan—Chills—Methotrexate—breast cancer	0.00012	0.000229	CcSEcCtD
Rizatriptan—Headache—Mitoxantrone—breast cancer	0.000119	0.000228	CcSEcCtD
Rizatriptan—Headache—Irinotecan—breast cancer	0.000119	0.000228	CcSEcCtD
Rizatriptan—Insomnia—Docetaxel—breast cancer	0.000119	0.000228	CcSEcCtD
Rizatriptan—Paraesthesia—Docetaxel—breast cancer	0.000118	0.000226	CcSEcCtD
Rizatriptan—Vomiting—Gemcitabine—breast cancer	0.000118	0.000225	CcSEcCtD
Rizatriptan—Bradycardia—Doxorubicin—breast cancer	0.000118	0.000225	CcSEcCtD
Rizatriptan—Dyspnoea—Docetaxel—breast cancer	0.000117	0.000224	CcSEcCtD
Rizatriptan—Somnolence—Docetaxel—breast cancer	0.000117	0.000224	CcSEcCtD
Rizatriptan—Mental disorder—Methotrexate—breast cancer	0.000117	0.000224	CcSEcCtD
Rizatriptan—Rash—Gemcitabine—breast cancer	0.000117	0.000224	CcSEcCtD
Rizatriptan—Dermatitis—Gemcitabine—breast cancer	0.000117	0.000223	CcSEcCtD
Rizatriptan—Tinnitus—Epirubicin—breast cancer	0.000117	0.000223	CcSEcCtD
Rizatriptan—Erythema—Methotrexate—breast cancer	0.000116	0.000222	CcSEcCtD
Rizatriptan—Headache—Gemcitabine—breast cancer	0.000116	0.000222	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000116	0.000222	CcSEcCtD
Rizatriptan—Flushing—Epirubicin—breast cancer	0.000116	0.000222	CcSEcCtD
Rizatriptan—Vomiting—Fluorouracil—breast cancer	0.000116	0.000222	CcSEcCtD
Rizatriptan—Dyspepsia—Docetaxel—breast cancer	0.000116	0.000221	CcSEcCtD
Rizatriptan—Insomnia—Capecitabine—breast cancer	0.000115	0.00022	CcSEcCtD
Rizatriptan—Hypoaesthesia—Doxorubicin—breast cancer	0.000115	0.00022	CcSEcCtD
Rizatriptan—Rash—Fluorouracil—breast cancer	0.000115	0.00022	CcSEcCtD
Rizatriptan—Dermatitis—Fluorouracil—breast cancer	0.000115	0.00022	CcSEcCtD
Rizatriptan—Pharyngitis—Doxorubicin—breast cancer	0.000115	0.000219	CcSEcCtD
Rizatriptan—Paraesthesia—Capecitabine—breast cancer	0.000115	0.000219	CcSEcCtD
Rizatriptan—Decreased appetite—Docetaxel—breast cancer	0.000115	0.000219	CcSEcCtD
Rizatriptan—Hypersensitivity—Paclitaxel—breast cancer	0.000115	0.000219	CcSEcCtD
Rizatriptan—Headache—Fluorouracil—breast cancer	0.000114	0.000218	CcSEcCtD
Rizatriptan—Dysgeusia—Methotrexate—breast cancer	0.000114	0.000218	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Docetaxel—breast cancer	0.000114	0.000217	CcSEcCtD
Rizatriptan—Dyspnoea—Capecitabine—breast cancer	0.000114	0.000217	CcSEcCtD
Rizatriptan—Fatigue—Docetaxel—breast cancer	0.000114	0.000217	CcSEcCtD
Rizatriptan—Angiopathy—Epirubicin—breast cancer	0.000113	0.000217	CcSEcCtD
Rizatriptan—Nausea—Mitoxantrone—breast cancer	0.000113	0.000216	CcSEcCtD
Rizatriptan—Nausea—Irinotecan—breast cancer	0.000113	0.000216	CcSEcCtD
Rizatriptan—Constipation—Docetaxel—breast cancer	0.000113	0.000215	CcSEcCtD
Rizatriptan—Pain—Docetaxel—breast cancer	0.000113	0.000215	CcSEcCtD
Rizatriptan—Dyspepsia—Capecitabine—breast cancer	0.000112	0.000214	CcSEcCtD
Rizatriptan—Chills—Epirubicin—breast cancer	0.000112	0.000214	CcSEcCtD
Rizatriptan—Arrhythmia—Epirubicin—breast cancer	0.000112	0.000213	CcSEcCtD
Rizatriptan—Asthenia—Paclitaxel—breast cancer	0.000112	0.000213	CcSEcCtD
Rizatriptan—Decreased appetite—Capecitabine—breast cancer	0.000111	0.000212	CcSEcCtD
Rizatriptan—Nausea—Gemcitabine—breast cancer	0.00011	0.000211	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Capecitabine—breast cancer	0.00011	0.00021	CcSEcCtD
Rizatriptan—Fatigue—Capecitabine—breast cancer	0.00011	0.00021	CcSEcCtD
Rizatriptan—Pruritus—Paclitaxel—breast cancer	0.00011	0.00021	CcSEcCtD
Rizatriptan—Vision blurred—Methotrexate—breast cancer	0.00011	0.000209	CcSEcCtD
Rizatriptan—Mental disorder—Epirubicin—breast cancer	0.00011	0.000209	CcSEcCtD
Rizatriptan—Constipation—Capecitabine—breast cancer	0.000109	0.000208	CcSEcCtD
Rizatriptan—Pain—Capecitabine—breast cancer	0.000109	0.000208	CcSEcCtD
Rizatriptan—Erythema—Epirubicin—breast cancer	0.000109	0.000208	CcSEcCtD
Rizatriptan—Feeling abnormal—Docetaxel—breast cancer	0.000109	0.000207	CcSEcCtD
Rizatriptan—Nausea—Fluorouracil—breast cancer	0.000108	0.000207	CcSEcCtD
Rizatriptan—Tinnitus—Doxorubicin—breast cancer	0.000108	0.000206	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Docetaxel—breast cancer	0.000108	0.000206	CcSEcCtD
Rizatriptan—Flushing—Doxorubicin—breast cancer	0.000107	0.000205	CcSEcCtD
Rizatriptan—Flatulence—Epirubicin—breast cancer	0.000107	0.000205	CcSEcCtD
Rizatriptan—Tension—Epirubicin—breast cancer	0.000107	0.000204	CcSEcCtD
Rizatriptan—Dysgeusia—Epirubicin—breast cancer	0.000107	0.000204	CcSEcCtD
Rizatriptan—Diarrhoea—Paclitaxel—breast cancer	0.000106	0.000203	CcSEcCtD
Rizatriptan—Nervousness—Epirubicin—breast cancer	0.000106	0.000202	CcSEcCtD
Rizatriptan—Feeling abnormal—Capecitabine—breast cancer	0.000105	0.000201	CcSEcCtD
Rizatriptan—Angiopathy—Doxorubicin—breast cancer	0.000105	0.000201	CcSEcCtD
Rizatriptan—Muscle spasms—Epirubicin—breast cancer	0.000105	0.0002	CcSEcCtD
Rizatriptan—Vertigo—Methotrexate—breast cancer	0.000105	0.0002	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Capecitabine—breast cancer	0.000104	0.000199	CcSEcCtD
Rizatriptan—Abdominal pain—Docetaxel—breast cancer	0.000104	0.000199	CcSEcCtD
Rizatriptan—Body temperature increased—Docetaxel—breast cancer	0.000104	0.000199	CcSEcCtD
Rizatriptan—Chills—Doxorubicin—breast cancer	0.000104	0.000198	CcSEcCtD
Rizatriptan—Arrhythmia—Doxorubicin—breast cancer	0.000103	0.000197	CcSEcCtD
Rizatriptan—Dizziness—Paclitaxel—breast cancer	0.000103	0.000196	CcSEcCtD
Rizatriptan—Vision blurred—Epirubicin—breast cancer	0.000103	0.000196	CcSEcCtD
Rizatriptan—Cough—Methotrexate—breast cancer	0.000102	0.000194	CcSEcCtD
Rizatriptan—Mental disorder—Doxorubicin—breast cancer	0.000101	0.000194	CcSEcCtD
Rizatriptan—Urticaria—Capecitabine—breast cancer	0.000101	0.000194	CcSEcCtD
Rizatriptan—Abdominal pain—Capecitabine—breast cancer	0.000101	0.000193	CcSEcCtD
Rizatriptan—Body temperature increased—Capecitabine—breast cancer	0.000101	0.000193	CcSEcCtD
Rizatriptan—Convulsion—Methotrexate—breast cancer	0.000101	0.000193	CcSEcCtD
Rizatriptan—Erythema—Doxorubicin—breast cancer	0.000101	0.000192	CcSEcCtD
Rizatriptan—Agitation—Epirubicin—breast cancer	0.0001	0.000191	CcSEcCtD
Rizatriptan—Flatulence—Doxorubicin—breast cancer	9.93e-05	0.00019	CcSEcCtD
Rizatriptan—Chest pain—Methotrexate—breast cancer	9.91e-05	0.000189	CcSEcCtD
Rizatriptan—Myalgia—Methotrexate—breast cancer	9.91e-05	0.000189	CcSEcCtD
Rizatriptan—Arthralgia—Methotrexate—breast cancer	9.91e-05	0.000189	CcSEcCtD
Rizatriptan—Tension—Doxorubicin—breast cancer	9.89e-05	0.000189	CcSEcCtD
Rizatriptan—Vomiting—Paclitaxel—breast cancer	9.88e-05	0.000189	CcSEcCtD
Rizatriptan—Dysgeusia—Doxorubicin—breast cancer	9.87e-05	0.000188	CcSEcCtD
Rizatriptan—Rash—Paclitaxel—breast cancer	9.8e-05	0.000187	CcSEcCtD
Rizatriptan—Dermatitis—Paclitaxel—breast cancer	9.79e-05	0.000187	CcSEcCtD
Rizatriptan—Discomfort—Methotrexate—breast cancer	9.79e-05	0.000187	CcSEcCtD
Rizatriptan—Nervousness—Doxorubicin—breast cancer	9.79e-05	0.000187	CcSEcCtD
Rizatriptan—Vertigo—Epirubicin—breast cancer	9.78e-05	0.000187	CcSEcCtD
Rizatriptan—Syncope—Epirubicin—breast cancer	9.77e-05	0.000186	CcSEcCtD
Rizatriptan—Headache—Paclitaxel—breast cancer	9.74e-05	0.000186	CcSEcCtD
Rizatriptan—Hypersensitivity—Docetaxel—breast cancer	9.71e-05	0.000185	CcSEcCtD
Rizatriptan—Muscle spasms—Doxorubicin—breast cancer	9.69e-05	0.000185	CcSEcCtD
Rizatriptan—Palpitations—Epirubicin—breast cancer	9.62e-05	0.000184	CcSEcCtD
Rizatriptan—Confusional state—Methotrexate—breast cancer	9.58e-05	0.000183	CcSEcCtD
Rizatriptan—Loss of consciousness—Epirubicin—breast cancer	9.57e-05	0.000183	CcSEcCtD
Rizatriptan—Cough—Epirubicin—breast cancer	9.5e-05	0.000181	CcSEcCtD
Rizatriptan—Anaphylactic shock—Methotrexate—breast cancer	9.5e-05	0.000181	CcSEcCtD
Rizatriptan—Vision blurred—Doxorubicin—breast cancer	9.5e-05	0.000181	CcSEcCtD
Rizatriptan—Asthenia—Docetaxel—breast cancer	9.45e-05	0.000181	CcSEcCtD
Rizatriptan—Convulsion—Epirubicin—breast cancer	9.44e-05	0.00018	CcSEcCtD
Rizatriptan—Hypertension—Epirubicin—breast cancer	9.4e-05	0.00018	CcSEcCtD
Rizatriptan—Hypersensitivity—Capecitabine—breast cancer	9.4e-05	0.000179	CcSEcCtD
Rizatriptan—Pruritus—Docetaxel—breast cancer	9.32e-05	0.000178	CcSEcCtD
Rizatriptan—Nervous system disorder—Methotrexate—breast cancer	9.31e-05	0.000178	CcSEcCtD
Rizatriptan—Arthralgia—Epirubicin—breast cancer	9.27e-05	0.000177	CcSEcCtD
Rizatriptan—Chest pain—Epirubicin—breast cancer	9.27e-05	0.000177	CcSEcCtD
Rizatriptan—Myalgia—Epirubicin—breast cancer	9.27e-05	0.000177	CcSEcCtD
Rizatriptan—Agitation—Doxorubicin—breast cancer	9.26e-05	0.000177	CcSEcCtD
Rizatriptan—Anxiety—Epirubicin—breast cancer	9.24e-05	0.000176	CcSEcCtD
Rizatriptan—Nausea—Paclitaxel—breast cancer	9.23e-05	0.000176	CcSEcCtD
Rizatriptan—Hyperhidrosis—Methotrexate—breast cancer	9.18e-05	0.000175	CcSEcCtD
Rizatriptan—Discomfort—Epirubicin—breast cancer	9.16e-05	0.000175	CcSEcCtD
Rizatriptan—Asthenia—Capecitabine—breast cancer	9.15e-05	0.000175	CcSEcCtD
Rizatriptan—Dry mouth—Epirubicin—breast cancer	9.07e-05	0.000173	CcSEcCtD
Rizatriptan—Vertigo—Doxorubicin—breast cancer	9.05e-05	0.000173	CcSEcCtD
Rizatriptan—Anorexia—Methotrexate—breast cancer	9.05e-05	0.000173	CcSEcCtD
Rizatriptan—Syncope—Doxorubicin—breast cancer	9.04e-05	0.000173	CcSEcCtD
Rizatriptan—Pruritus—Capecitabine—breast cancer	9.03e-05	0.000172	CcSEcCtD
Rizatriptan—Diarrhoea—Docetaxel—breast cancer	9.02e-05	0.000172	CcSEcCtD
Rizatriptan—Confusional state—Epirubicin—breast cancer	8.96e-05	0.000171	CcSEcCtD
Rizatriptan—Palpitations—Doxorubicin—breast cancer	8.9e-05	0.00017	CcSEcCtD
Rizatriptan—Oedema—Epirubicin—breast cancer	8.89e-05	0.00017	CcSEcCtD
Rizatriptan—Anaphylactic shock—Epirubicin—breast cancer	8.89e-05	0.00017	CcSEcCtD
Rizatriptan—Loss of consciousness—Doxorubicin—breast cancer	8.86e-05	0.000169	CcSEcCtD
Rizatriptan—Cough—Doxorubicin—breast cancer	8.79e-05	0.000168	CcSEcCtD
Rizatriptan—Shock—Epirubicin—breast cancer	8.74e-05	0.000167	CcSEcCtD
Rizatriptan—Convulsion—Doxorubicin—breast cancer	8.73e-05	0.000167	CcSEcCtD
Rizatriptan—Diarrhoea—Capecitabine—breast cancer	8.73e-05	0.000167	CcSEcCtD
Rizatriptan—Nervous system disorder—Epirubicin—breast cancer	8.72e-05	0.000166	CcSEcCtD
Rizatriptan—Dizziness—Docetaxel—breast cancer	8.71e-05	0.000166	CcSEcCtD
Rizatriptan—Hypertension—Doxorubicin—breast cancer	8.7e-05	0.000166	CcSEcCtD
Rizatriptan—Tachycardia—Epirubicin—breast cancer	8.67e-05	0.000166	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Methotrexate—breast cancer	8.65e-05	0.000165	CcSEcCtD
Rizatriptan—Hyperhidrosis—Epirubicin—breast cancer	8.59e-05	0.000164	CcSEcCtD
Rizatriptan—Insomnia—Methotrexate—breast cancer	8.59e-05	0.000164	CcSEcCtD
Rizatriptan—Myalgia—Doxorubicin—breast cancer	8.58e-05	0.000164	CcSEcCtD
Rizatriptan—Arthralgia—Doxorubicin—breast cancer	8.58e-05	0.000164	CcSEcCtD
Rizatriptan—Chest pain—Doxorubicin—breast cancer	8.58e-05	0.000164	CcSEcCtD
Rizatriptan—Anxiety—Doxorubicin—breast cancer	8.55e-05	0.000163	CcSEcCtD
Rizatriptan—Paraesthesia—Methotrexate—breast cancer	8.53e-05	0.000163	CcSEcCtD
Rizatriptan—Discomfort—Doxorubicin—breast cancer	8.48e-05	0.000162	CcSEcCtD
Rizatriptan—Anorexia—Epirubicin—breast cancer	8.47e-05	0.000162	CcSEcCtD
Rizatriptan—Dyspnoea—Methotrexate—breast cancer	8.47e-05	0.000162	CcSEcCtD
Rizatriptan—Somnolence—Methotrexate—breast cancer	8.44e-05	0.000161	CcSEcCtD
Rizatriptan—Dizziness—Capecitabine—breast cancer	8.44e-05	0.000161	CcSEcCtD
Rizatriptan—Dry mouth—Doxorubicin—breast cancer	8.39e-05	0.00016	CcSEcCtD
Rizatriptan—Vomiting—Docetaxel—breast cancer	8.38e-05	0.00016	CcSEcCtD
Rizatriptan—Dyspepsia—Methotrexate—breast cancer	8.36e-05	0.00016	CcSEcCtD
Rizatriptan—Rash—Docetaxel—breast cancer	8.31e-05	0.000159	CcSEcCtD
Rizatriptan—Dermatitis—Docetaxel—breast cancer	8.3e-05	0.000158	CcSEcCtD
Rizatriptan—Confusional state—Doxorubicin—breast cancer	8.29e-05	0.000158	CcSEcCtD
Rizatriptan—Decreased appetite—Methotrexate—breast cancer	8.26e-05	0.000158	CcSEcCtD
Rizatriptan—Headache—Docetaxel—breast cancer	8.25e-05	0.000158	CcSEcCtD
Rizatriptan—Oedema—Doxorubicin—breast cancer	8.22e-05	0.000157	CcSEcCtD
Rizatriptan—Anaphylactic shock—Doxorubicin—breast cancer	8.22e-05	0.000157	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Methotrexate—breast cancer	8.2e-05	0.000157	CcSEcCtD
Rizatriptan—Fatigue—Methotrexate—breast cancer	8.19e-05	0.000156	CcSEcCtD
Rizatriptan—Pain—Methotrexate—breast cancer	8.12e-05	0.000155	CcSEcCtD
Rizatriptan—Vomiting—Capecitabine—breast cancer	8.11e-05	0.000155	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Epirubicin—breast cancer	8.1e-05	0.000155	CcSEcCtD
Rizatriptan—Shock—Doxorubicin—breast cancer	8.09e-05	0.000154	CcSEcCtD
Rizatriptan—Nervous system disorder—Doxorubicin—breast cancer	8.06e-05	0.000154	CcSEcCtD
Rizatriptan—Rash—Capecitabine—breast cancer	8.04e-05	0.000154	CcSEcCtD
Rizatriptan—Insomnia—Epirubicin—breast cancer	8.04e-05	0.000153	CcSEcCtD
Rizatriptan—Dermatitis—Capecitabine—breast cancer	8.04e-05	0.000153	CcSEcCtD
Rizatriptan—Tachycardia—Doxorubicin—breast cancer	8.03e-05	0.000153	CcSEcCtD
Rizatriptan—Headache—Capecitabine—breast cancer	7.99e-05	0.000153	CcSEcCtD
Rizatriptan—Paraesthesia—Epirubicin—breast cancer	7.98e-05	0.000152	CcSEcCtD
Rizatriptan—Hyperhidrosis—Doxorubicin—breast cancer	7.95e-05	0.000152	CcSEcCtD
Rizatriptan—Dyspnoea—Epirubicin—breast cancer	7.92e-05	0.000151	CcSEcCtD
Rizatriptan—Somnolence—Epirubicin—breast cancer	7.9e-05	0.000151	CcSEcCtD
Rizatriptan—Anorexia—Doxorubicin—breast cancer	7.84e-05	0.00015	CcSEcCtD
Rizatriptan—Nausea—Docetaxel—breast cancer	7.83e-05	0.000149	CcSEcCtD
Rizatriptan—Feeling abnormal—Methotrexate—breast cancer	7.83e-05	0.000149	CcSEcCtD
Rizatriptan—Dyspepsia—Epirubicin—breast cancer	7.82e-05	0.000149	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Methotrexate—breast cancer	7.77e-05	0.000148	CcSEcCtD
Rizatriptan—Decreased appetite—Epirubicin—breast cancer	7.73e-05	0.000148	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Epirubicin—breast cancer	7.67e-05	0.000147	CcSEcCtD
Rizatriptan—Fatigue—Epirubicin—breast cancer	7.66e-05	0.000146	CcSEcCtD
Rizatriptan—Constipation—Epirubicin—breast cancer	7.6e-05	0.000145	CcSEcCtD
Rizatriptan—Pain—Epirubicin—breast cancer	7.6e-05	0.000145	CcSEcCtD
Rizatriptan—Nausea—Capecitabine—breast cancer	7.58e-05	0.000145	CcSEcCtD
Rizatriptan—Urticaria—Methotrexate—breast cancer	7.54e-05	0.000144	CcSEcCtD
Rizatriptan—Abdominal pain—Methotrexate—breast cancer	7.51e-05	0.000143	CcSEcCtD
Rizatriptan—Body temperature increased—Methotrexate—breast cancer	7.51e-05	0.000143	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Doxorubicin—breast cancer	7.49e-05	0.000143	CcSEcCtD
Rizatriptan—Insomnia—Doxorubicin—breast cancer	7.44e-05	0.000142	CcSEcCtD
Rizatriptan—Paraesthesia—Doxorubicin—breast cancer	7.38e-05	0.000141	CcSEcCtD
Rizatriptan—Dyspnoea—Doxorubicin—breast cancer	7.33e-05	0.00014	CcSEcCtD
Rizatriptan—Feeling abnormal—Epirubicin—breast cancer	7.32e-05	0.00014	CcSEcCtD
Rizatriptan—Somnolence—Doxorubicin—breast cancer	7.31e-05	0.00014	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Epirubicin—breast cancer	7.27e-05	0.000139	CcSEcCtD
Rizatriptan—Dyspepsia—Doxorubicin—breast cancer	7.24e-05	0.000138	CcSEcCtD
Rizatriptan—Decreased appetite—Doxorubicin—breast cancer	7.15e-05	0.000136	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Doxorubicin—breast cancer	7.1e-05	0.000136	CcSEcCtD
Rizatriptan—Fatigue—Doxorubicin—breast cancer	7.09e-05	0.000135	CcSEcCtD
Rizatriptan—Urticaria—Epirubicin—breast cancer	7.06e-05	0.000135	CcSEcCtD
Rizatriptan—Constipation—Doxorubicin—breast cancer	7.03e-05	0.000134	CcSEcCtD
Rizatriptan—Pain—Doxorubicin—breast cancer	7.03e-05	0.000134	CcSEcCtD
Rizatriptan—Abdominal pain—Epirubicin—breast cancer	7.03e-05	0.000134	CcSEcCtD
Rizatriptan—Body temperature increased—Epirubicin—breast cancer	7.03e-05	0.000134	CcSEcCtD
Rizatriptan—Hypersensitivity—Methotrexate—breast cancer	7e-05	0.000134	CcSEcCtD
Rizatriptan—Asthenia—Methotrexate—breast cancer	6.81e-05	0.00013	CcSEcCtD
Rizatriptan—Feeling abnormal—Doxorubicin—breast cancer	6.78e-05	0.000129	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Doxorubicin—breast cancer	6.72e-05	0.000128	CcSEcCtD
Rizatriptan—Pruritus—Methotrexate—breast cancer	6.72e-05	0.000128	CcSEcCtD
Rizatriptan—Hypersensitivity—Epirubicin—breast cancer	6.55e-05	0.000125	CcSEcCtD
Rizatriptan—Urticaria—Doxorubicin—breast cancer	6.53e-05	0.000125	CcSEcCtD
Rizatriptan—Abdominal pain—Doxorubicin—breast cancer	6.5e-05	0.000124	CcSEcCtD
Rizatriptan—Body temperature increased—Doxorubicin—breast cancer	6.5e-05	0.000124	CcSEcCtD
Rizatriptan—Diarrhoea—Methotrexate—breast cancer	6.5e-05	0.000124	CcSEcCtD
Rizatriptan—Asthenia—Epirubicin—breast cancer	6.38e-05	0.000122	CcSEcCtD
Rizatriptan—Pruritus—Epirubicin—breast cancer	6.29e-05	0.00012	CcSEcCtD
Rizatriptan—Dizziness—Methotrexate—breast cancer	6.28e-05	0.00012	CcSEcCtD
Rizatriptan—Diarrhoea—Epirubicin—breast cancer	6.08e-05	0.000116	CcSEcCtD
Rizatriptan—Hypersensitivity—Doxorubicin—breast cancer	6.06e-05	0.000116	CcSEcCtD
Rizatriptan—Vomiting—Methotrexate—breast cancer	6.04e-05	0.000115	CcSEcCtD
Rizatriptan—Rash—Methotrexate—breast cancer	5.99e-05	0.000114	CcSEcCtD
Rizatriptan—Dermatitis—Methotrexate—breast cancer	5.98e-05	0.000114	CcSEcCtD
Rizatriptan—Headache—Methotrexate—breast cancer	5.95e-05	0.000114	CcSEcCtD
Rizatriptan—Asthenia—Doxorubicin—breast cancer	5.9e-05	0.000113	CcSEcCtD
Rizatriptan—Dizziness—Epirubicin—breast cancer	5.88e-05	0.000112	CcSEcCtD
Rizatriptan—Pruritus—Doxorubicin—breast cancer	5.82e-05	0.000111	CcSEcCtD
Rizatriptan—Vomiting—Epirubicin—breast cancer	5.65e-05	0.000108	CcSEcCtD
Rizatriptan—Nausea—Methotrexate—breast cancer	5.64e-05	0.000108	CcSEcCtD
Rizatriptan—Diarrhoea—Doxorubicin—breast cancer	5.63e-05	0.000107	CcSEcCtD
Rizatriptan—Rash—Epirubicin—breast cancer	5.6e-05	0.000107	CcSEcCtD
Rizatriptan—Dermatitis—Epirubicin—breast cancer	5.6e-05	0.000107	CcSEcCtD
Rizatriptan—Headache—Epirubicin—breast cancer	5.57e-05	0.000106	CcSEcCtD
Rizatriptan—Dizziness—Doxorubicin—breast cancer	5.44e-05	0.000104	CcSEcCtD
Rizatriptan—Nausea—Epirubicin—breast cancer	5.28e-05	0.000101	CcSEcCtD
Rizatriptan—Vomiting—Doxorubicin—breast cancer	5.23e-05	9.98e-05	CcSEcCtD
Rizatriptan—Rash—Doxorubicin—breast cancer	5.19e-05	9.9e-05	CcSEcCtD
Rizatriptan—Dermatitis—Doxorubicin—breast cancer	5.18e-05	9.89e-05	CcSEcCtD
Rizatriptan—Headache—Doxorubicin—breast cancer	5.15e-05	9.84e-05	CcSEcCtD
Rizatriptan—Nausea—Doxorubicin—breast cancer	4.88e-05	9.33e-05	CcSEcCtD
Rizatriptan—HTR1D—Signaling Pathways—PIK3CG—breast cancer	1.78e-05	9.14e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—APC—breast cancer	1.78e-05	9.14e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—KIT—breast cancer	1.78e-05	9.14e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—FGF1—breast cancer	1.76e-05	9.08e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CSF2—breast cancer	1.76e-05	9.08e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—RAF1—breast cancer	1.76e-05	9.06e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—EGF—breast cancer	1.75e-05	9.04e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NRG1—breast cancer	1.75e-05	9.02e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—APC—breast cancer	1.74e-05	8.95e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PIK3CG—breast cancer	1.74e-05	8.95e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—KIT—breast cancer	1.74e-05	8.95e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—H2AFX—breast cancer	1.74e-05	8.95e-05	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—IL2—breast cancer	1.74e-05	8.95e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—E2F1—breast cancer	1.73e-05	8.89e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—EGF—breast cancer	1.72e-05	8.85e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—PIK3CB—breast cancer	1.72e-05	8.85e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—SRC—breast cancer	1.7e-05	8.78e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—MAPK3—breast cancer	1.7e-05	8.76e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	1.69e-05	8.72e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—BRAF—breast cancer	1.67e-05	8.6e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—MAPK3—breast cancer	1.66e-05	8.58e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—VEGFA—breast cancer	1.66e-05	8.55e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—SPP1—breast cancer	1.66e-05	8.54e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—CXCL8—breast cancer	1.65e-05	8.5e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—STAT3—breast cancer	1.64e-05	8.47e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—DPYD—breast cancer	1.64e-05	8.46e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—MED12—breast cancer	1.64e-05	8.46e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ERBB3—breast cancer	1.64e-05	8.45e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PIK3CD—breast cancer	1.64e-05	8.44e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—FGFR2—breast cancer	1.64e-05	8.43e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—BRAF—breast cancer	1.63e-05	8.42e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IGF1—breast cancer	1.63e-05	8.37e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—AKT2—breast cancer	1.62e-05	8.37e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—EGFR—breast cancer	1.62e-05	8.33e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ALDOA—breast cancer	1.62e-05	8.33e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—ALB—breast cancer	1.62e-05	8.33e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IGF1—breast cancer	1.59e-05	8.2e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—AKT2—breast cancer	1.59e-05	8.19e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—EGFR—breast cancer	1.58e-05	8.16e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—IL2—breast cancer	1.58e-05	8.13e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TERT—breast cancer	1.57e-05	8.1e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—MAPK3—breast cancer	1.57e-05	8.09e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—NCOA3—breast cancer	1.57e-05	8.09e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PIK3CD—breast cancer	1.56e-05	8.04e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—SLC2A2—breast cancer	1.56e-05	8.03e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—NOS3—breast cancer	1.55e-05	7.97e-05	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—PIK3CA—breast cancer	1.55e-05	7.96e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—SERPINE1—breast cancer	1.54e-05	7.95e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.54e-05	7.95e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PIK3CD—breast cancer	1.53e-05	7.87e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—KRAS—breast cancer	1.53e-05	7.87e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—MYC—breast cancer	1.53e-05	7.87e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ABCG2—breast cancer	1.53e-05	7.87e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CPT1A—breast cancer	1.53e-05	7.87e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—MTR—breast cancer	1.53e-05	7.87e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—FGFR1—breast cancer	1.53e-05	7.86e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—TGFB1—breast cancer	1.52e-05	7.85e-05	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—PIK3CA—breast cancer	1.51e-05	7.8e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—SERPINE1—breast cancer	1.51e-05	7.79e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—HIF1A—breast cancer	1.5e-05	7.74e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—HPGDS—breast cancer	1.5e-05	7.71e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—KRAS—breast cancer	1.5e-05	7.71e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—EGFR—breast cancer	1.49e-05	7.7e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—HBA1—breast cancer	1.49e-05	7.67e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NOS3—breast cancer	1.47e-05	7.59e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—LEP—breast cancer	1.47e-05	7.56e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CAV1—breast cancer	1.45e-05	7.49e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GSTT1—breast cancer	1.45e-05	7.48e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ACHE—breast cancer	1.45e-05	7.48e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NOS3—breast cancer	1.44e-05	7.43e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—KDR—breast cancer	1.44e-05	7.4e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PIK3CB—breast cancer	1.43e-05	7.35e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PTGS2—breast cancer	1.41e-05	7.29e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—KRAS—breast cancer	1.41e-05	7.27e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—PIK3CA—breast cancer	1.4e-05	7.23e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ESR1—breast cancer	1.4e-05	7.22e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MDM2—breast cancer	1.4e-05	7.2e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—RAF1—breast cancer	1.39e-05	7.18e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—RELA—breast cancer	1.39e-05	7.15e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—FN1—breast cancer	1.38e-05	7.13e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—ERBB2—breast cancer	1.38e-05	7.1e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYP17A1—breast cancer	1.38e-05	7.08e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—PIK3CA—breast cancer	1.37e-05	7.08e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MDM2—breast cancer	1.37e-05	7.05e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NFKBIA—breast cancer	1.37e-05	7.04e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—RAF1—breast cancer	1.36e-05	7.03e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PTGS1—breast cancer	1.36e-05	7.01e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ENO1—breast cancer	1.36e-05	7.01e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MTOR—breast cancer	1.36e-05	7.01e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PIK3CB—breast cancer	1.36e-05	7.01e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—RELA—breast cancer	1.36e-05	7e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.36e-05	6.99e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NOTCH1—breast cancer	1.35e-05	6.97e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—ERBB2—breast cancer	1.35e-05	6.95e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.34e-05	6.9e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYP2D6—breast cancer	1.33e-05	6.88e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MTOR—breast cancer	1.33e-05	6.86e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PIK3CB—breast cancer	1.33e-05	6.86e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—APC—breast cancer	1.32e-05	6.82e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PIK3CG—breast cancer	1.32e-05	6.82e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—KIT—breast cancer	1.32e-05	6.82e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—NCOA2—breast cancer	1.31e-05	6.75e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—EGF—breast cancer	1.31e-05	6.74e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CXCL8—breast cancer	1.31e-05	6.73e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—HRAS—breast cancer	1.3e-05	6.69e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—PIK3CA—breast cancer	1.3e-05	6.68e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CXCL8—breast cancer	1.28e-05	6.59e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CDKN1B—breast cancer	1.28e-05	6.58e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—HRAS—breast cancer	1.27e-05	6.55e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—FASN—breast cancer	1.27e-05	6.55e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—MAPK3—breast cancer	1.27e-05	6.53e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—BCHE—breast cancer	1.27e-05	6.52e-05	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—AKT1—breast cancer	1.26e-05	6.5e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—TP53—breast cancer	1.25e-05	6.46e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CASP3—breast cancer	1.25e-05	6.44e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—SLC5A5—breast cancer	1.25e-05	6.44e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CDKN1B—breast cancer	1.25e-05	6.44e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IL2—breast cancer	1.25e-05	6.43e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—BRAF—breast cancer	1.24e-05	6.41e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—IL6—breast cancer	1.24e-05	6.4e-05	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—AKT1—breast cancer	1.24e-05	6.37e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PTEN—breast cancer	1.23e-05	6.35e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CASP3—breast cancer	1.23e-05	6.31e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IL2—breast cancer	1.22e-05	6.3e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CCND1—breast cancer	1.22e-05	6.27e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—IL6—breast cancer	1.22e-05	6.27e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—JUN—breast cancer	1.22e-05	6.26e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IGF1—breast cancer	1.21e-05	6.25e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—AKT2—breast cancer	1.21e-05	6.24e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—NQO1—breast cancer	1.21e-05	6.22e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—SLC2A1—breast cancer	1.21e-05	6.22e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—EGFR—breast cancer	1.21e-05	6.21e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CTNNB1—breast cancer	1.21e-05	6.21e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—HRAS—breast cancer	1.2e-05	6.18e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CCND1—breast cancer	1.19e-05	6.14e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—JUN—breast cancer	1.19e-05	6.13e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MMP9—breast cancer	1.18e-05	6.09e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.18e-05	6.09e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CTNNB1—breast cancer	1.18e-05	6.08e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CDKN1A—breast cancer	1.18e-05	6.07e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYP3A4—breast cancer	1.18e-05	6.06e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PTEN—breast cancer	1.18e-05	6.05e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.17e-05	6.03e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PIK3CD—breast cancer	1.16e-05	6e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MMP9—breast cancer	1.16e-05	5.96e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYP1B1—breast cancer	1.16e-05	5.96e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CDKN1A—breast cancer	1.15e-05	5.94e-05	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—PIK3CA—breast cancer	1.15e-05	5.94e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—SERPINE1—breast cancer	1.15e-05	5.93e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PTEN—breast cancer	1.15e-05	5.93e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MAPK8—breast cancer	1.15e-05	5.92e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—IL6—breast cancer	1.15e-05	5.91e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—AKT1—breast cancer	1.15e-05	5.91e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—KRAS—breast cancer	1.14e-05	5.87e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—HSP90AA1—breast cancer	1.14e-05	5.85e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MAPK8—breast cancer	1.13e-05	5.8e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—AKT1—breast cancer	1.12e-05	5.78e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—NCOA1—breast cancer	1.1e-05	5.69e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NOS3—breast cancer	1.1e-05	5.66e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—SRC—breast cancer	1.09e-05	5.61e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—STK11—breast cancer	1.09e-05	5.61e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYP19A1—breast cancer	1.09e-05	5.61e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—SRC—breast cancer	1.07e-05	5.5e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—VEGFA—breast cancer	1.06e-05	5.47e-05	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—AKT1—breast cancer	1.06e-05	5.46e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—STAT3—breast cancer	1.05e-05	5.41e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—PIK3CA—breast cancer	1.05e-05	5.39e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MDM2—breast cancer	1.04e-05	5.37e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—VEGFA—breast cancer	1.04e-05	5.35e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—RAF1—breast cancer	1.04e-05	5.35e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—RELA—breast cancer	1.03e-05	5.33e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—STAT3—breast cancer	1.03e-05	5.3e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ERBB2—breast cancer	1.03e-05	5.3e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.02e-05	5.26e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PIK3CB—breast cancer	1.01e-05	5.23e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MTOR—breast cancer	1.01e-05	5.23e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—COMT—breast cancer	1.01e-05	5.21e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GSTP1—breast cancer	1.01e-05	5.19e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MAPK3—breast cancer	1e-05	5.17e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—HMOX1—breast cancer	9.93e-06	5.12e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ITPR1—breast cancer	9.91e-06	5.1e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MAPK3—breast cancer	9.83e-06	5.07e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MYC—breast cancer	9.77e-06	5.03e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CXCL8—breast cancer	9.75e-06	5.02e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—TGFB1—breast cancer	9.74e-06	5.02e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—HRAS—breast cancer	9.69e-06	4.99e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MYC—breast cancer	9.56e-06	4.93e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—EGFR—breast cancer	9.55e-06	4.92e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—TGFB1—breast cancer	9.54e-06	4.91e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ABCB1—breast cancer	9.53e-06	4.91e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CDKN1B—breast cancer	9.52e-06	4.9e-05	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—AKT1—breast cancer	9.42e-06	4.85e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—TYMS—breast cancer	9.36e-06	4.82e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—EGFR—breast cancer	9.36e-06	4.82e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CASP3—breast cancer	9.33e-06	4.81e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IL2—breast cancer	9.32e-06	4.8e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—IL6—breast cancer	9.27e-06	4.78e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—NCOR1—breast cancer	9.25e-06	4.77e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PLA2G4A—breast cancer	9.25e-06	4.77e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GSTM1—breast cancer	9.25e-06	4.77e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CCND1—breast cancer	9.08e-06	4.68e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—JUN—breast cancer	9.06e-06	4.67e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—KRAS—breast cancer	9.03e-06	4.65e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CTNNB1—breast cancer	9e-06	4.63e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GPX1—breast cancer	8.86e-06	4.56e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—KRAS—breast cancer	8.84e-06	4.55e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MMP9—breast cancer	8.82e-06	4.54e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CDKN1A—breast cancer	8.79e-06	4.53e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYP1A1—breast cancer	8.77e-06	4.52e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PTEN—breast cancer	8.77e-06	4.52e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PIK3CA—breast cancer	8.7e-06	4.48e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ERCC2—breast cancer	8.7e-06	4.48e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MAPK8—breast cancer	8.58e-06	4.42e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—AKT1—breast cancer	8.55e-06	4.41e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PIK3CA—breast cancer	8.29e-06	4.27e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—MTHFR—breast cancer	8.18e-06	4.21e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—SRC—breast cancer	8.13e-06	4.19e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PIK3CA—breast cancer	8.12e-06	4.18e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—TP53—breast cancer	8.02e-06	4.13e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—VEGFA—breast cancer	7.92e-06	4.08e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—TP53—breast cancer	7.85e-06	4.05e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—STAT3—breast cancer	7.84e-06	4.04e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—HRAS—breast cancer	7.67e-06	3.95e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CAV1—breast cancer	7.54e-06	3.89e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—HRAS—breast cancer	7.51e-06	3.87e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MAPK3—breast cancer	7.49e-06	3.86e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IL6—breast cancer	7.34e-06	3.78e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MYC—breast cancer	7.29e-06	3.75e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TGFB1—breast cancer	7.27e-06	3.74e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	7.21e-06	3.71e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IL6—breast cancer	7.19e-06	3.7e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—EGFR—breast cancer	7.13e-06	3.67e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—AKT1—breast cancer	7.11e-06	3.66e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PIK3CG—breast cancer	6.87e-06	3.54e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—AKT1—breast cancer	6.77e-06	3.49e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—KRAS—breast cancer	6.73e-06	3.47e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—AKT1—breast cancer	6.63e-06	3.42e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PIK3CA—breast cancer	6.19e-06	3.19e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PIK3CD—breast cancer	6.04e-06	3.11e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TP53—breast cancer	5.98e-06	3.08e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ALB—breast cancer	5.96e-06	3.07e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—HRAS—breast cancer	5.72e-06	2.95e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—NOS3—breast cancer	5.7e-06	2.94e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IL6—breast cancer	5.48e-06	2.82e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PIK3CB—breast cancer	5.26e-06	2.71e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PTGS2—breast cancer	5.22e-06	2.69e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—AKT1—breast cancer	5.05e-06	2.6e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PTEN—breast cancer	4.55e-06	2.34e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PIK3CA—breast cancer	3.21e-06	1.65e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—AKT1—breast cancer	2.62e-06	1.35e-05	CbGpPWpGaD
